Drug Discovery Market Reports
(30 Reports)
Find the information you need on the drug discovery industry. The Kalorama Information collection of research reports provides insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, size, and growth in US and global markets are also featured. You’ll find the latest information regarding protein biomarkers, emerging cancer vaccines, emerging drug therapies, outsourcing trends, and more.
|
Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry.
Kalorama Information's Outsourcing in Drug Development is
|
more...
|
Oct 1, 2008
|
$3,500.00
|
|
Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends)
The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel
|
more...
|
Aug 1, 2008
|
$3,500.00
|
|
The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments.
|
more...
|
Aug 1, 2008
|
$2,995.00
|
|
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent
|
more...
|
May 1, 2008
|
$3,500.00
|
|
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.
For market-watchers in the pharmaceutical industry, the
|
more...
|
Mar 1, 2008
|
$3,995.00
|
|
Gene Expression Profiling Markets
Parts of the gene expression analysis market continue to develop in a somewhat predictable manner, whereas other segments are becoming increasingly complex and volatile. The main products—microarrays and RT-PCR—continue to gain widespread acceptance and to see revenues grow rapidly. However, different products and applications are increasingly being introduced,
|
more...
Search inside this report
|
Jan 1, 2008
|
$3,995.00
|
|
Worldwide Market for Rheumatoid Arthritis and Lupus Treatments ( Autoimmune Disease Markets )
Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. Additionally, autoimmune diseases are accounting for a growing
|
more...
Search inside this report
|
Jan 1, 2008
|
$3,500.00
|
|
The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)
Kalorama's 2nd edition of The World Cardiovascular Drugs Market , in its 2nd edition, will steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments. Analyst Mary
|
more...
Search inside this report
|
Dec 1, 2007
|
$3,995.00
|
|
Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays, 3rd. Edition
Analytical microchips can be considered one of the fastest growing technology segments in life sciences. The range of applications to which these miniature laboratories may be directed is very broad — covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis.
|
more...
|
Nov 1, 2007
|
$3,995.00
|
|
Early Toxicology: Markets and Approaches
Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient
|
more...
|
Jun 1, 2007
|
$3,495.00
|
|
Global Tuberculosis Diagnostics and Treatment Markets
The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated. Though nearly extinct in the 20th century, over 1.6 billion people worldwide suffer from tuberculosis, and it is now presenting a major crisis in public health circles.
As illustrated by Kenneth G.
|
more...
Search inside this report
|
Jun 1, 2007
|
$3,995.00
|
|
Biomarkers: A Market Briefing
Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials.
|
more...
Search inside this report
|
Jan 1, 2007
|
$1,995.00
|
|
Mass Spectrometry in Protein Biomarker Applications: Software, Services, and Instrument Markets
Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. However, they also have broad
|
more...
Buy by the section | Search inside this report
|
Nov 1, 2006
|
$2,995.00
|
|
Outsourcing in Drug Development: The Contract Research (CRO) Market, 2nd Edition
CRO is a need-to know practice in pharmaceutical marketing today; but information is not always easy to find. This second edition of Kalorama’s best-selling look at the clinical contract research industry provides the key information competitors need to navigate the complexities and costs of clinical research in the drug
|
more...
Buy by the section | Search inside this report
|
May 1, 2006
|
$3,500.00
|
|
Men's Health: The Market for Current and Emerging Drug Therapies, 2nd Edition
This complete re-evaluation of the Men’s Health market focuses on the following prescription drug treatment segments:
Men’s Cancer
Men’s Sexual Dysfunction
Men’s Sexually Transmitted Diseases
Men’s Urinary Conditions
Andropause
The report covers drugs used for the treatment of prostate cancer, testicular cancer, impotence, premature ejaculation, and benign prostatic
|
more...
Buy by the section | Search inside this report
|
May 1, 2006
|
$3,550.00
|
|
The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
There are hundreds of drugs in Phase III clinical trials, of which almost 200 of them may gain market approval from the FDA in the coming 5 years. Which drugs will make it and how these drugs impact existing pharmaceutical markets in terms of overall size and competitive share is
|
more...
Buy by the section | Search inside this report
|
Mar 1, 2006
|
$3,500.00
|
|
Outsourcing in Drug Discovery, 2nd Edition
In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up.
This new report is designed
|
more...
Buy by the section | Search inside this report
|
Jan 1, 2006
|
$2,995.00
|
|
Informatics in Drug Discovery: The Evolving Information Technology Marketplace
Within the world of life science research, informatics plays a key role. A few years ago, this market space was occupied primarily by a few niche players, but over the past five years, established companies have expanded their offerings and hundreds of new software companies have surfaced.
|
more...
Buy by the section | Search inside this report
|
May 1, 2005
|
$3,000.00
|
|
Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited
Ten years ago, high throughput screening (HTS) was being touted as the answer to improving productivity in drug discovery. If screening thousands of compounds a week was good, screening hundreds of thousands would be even better. This led to the boom in Ultra HTS (UHTS), manufacturing-scale systems, and
|
more...
Buy by the section | Search inside this report
|
Jun 1, 2004
|
$2,995.00
|
|
Outsourcing in Drug Development: The Contract Research Market from Preclinical to Phase III
The cost of drug development has soared during the past ten years compelling pharmaceutical and biotechnology companies to look for new, smarter ways of conducting clinical research. Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their
|
more...
Buy by the section | Search inside this report
|
Jan 1, 2004
|
$3,500.00
|
|
The Market for Lead Optimization Tools and Services: Applying the new "-omics" to enhance drug discovery
The process of creating a new drug is lengthy and complex. From discovery to development to market, there are numerous pitfalls. In this report, Kalorama focuses on one of the trickiest yet also most promising areas: the interface between discovery and development known as lead optimization.
The pressure is
|
more...
Buy by the section | Search inside this report
|
Nov 1, 2003
|
$1,875.00
|
|
OTC Women's Health: A Supplement to Women's Health, 3rd Edition
The OTC women’s health market encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is driven by several factors including increasing number of baby boomers entering old age, increasing incidences of diseases; product demand; and several others.
In response to
|
more...
Search inside this report
|
Aug 1, 2003
|
$1,496.00
|
|
Men's Health: The World Market for Current and Emerging Drug Therapies
This Kalorama Information report—Men’s Health: The World Market for Current and Emerging Drug Therapies—focuses on treatment segments in which men are affected. These segments include:
· Men’s Cancer
· Sexual Function
· Sexually Transmitted Diseases
· Urinary Conditions
· Andropause
The report covers drugs that are used
|
more...
Buy by the section | Search inside this report
|
Aug 1, 2003
|
$2,625.00
|
|
Outsourcing in Drug Discovery
The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are aggressively pursuing a range of outsourcing agreements.
|
more...
Buy by the section | Search inside this report
|
May 1, 2003
|
$2,062.00
|
|
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays
The world of analytical microchips is the fastest growing technology segment in the life sciences today. The range of applications to which these miniature laboratories may be directed is very broad--covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the
|
more...
Buy by the section | Search inside this report
|
Mar 1, 2003
|
$2,625.00
|
|
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Anesthesia Drugs: Worldwide Markets
Vaccines: The World Market
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
The World Market for Pain Management Drugs and Devices, 2nd Edition
Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
The Worldwide Market for Dialysis Equipment, Supplies, and Services, 2nd Edition
|